Loomis Sayles & CO L P Mirum Pharmaceuticals, Inc. Transaction History
Loomis Sayles & CO L P
- $79.2 Billion
- Q4 2024
A detailed history of Loomis Sayles & CO L P transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Loomis Sayles & CO L P holds 578,024 shares of MIRM stock, worth $27.5 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
578,024
Previous 499,316
15.76%
Holding current value
$27.5 Million
Previous $19.5 Million
22.74%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$313 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$218 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$154 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$133 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$124 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.75B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...